Author

D. Heiman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. D. Cherniack· 1 shared G. Getz· 1 shared J. F. Gainor· 1 shared J. Kim· 1 shared M. Miller· 1 shared National Cancer Institute Center for Cancer Genomics Tumor Molecular Pathology (TMP) AWG· 1 shared P. W. Laird· 1 shared S. Anand· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. D. Cherniack

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

High-resolution lung adenocarcinoma expression subtypes identify tumors with dependencies on MET, CDK4, CDK6, and PD-L1

W. Roh, Y. Geffen, M. Miller, S. Anand, J. Kim, D. Heiman, J. F. Gainor, P. W. Laird, A. D. Cherniack, National Cancer Institute Center for Cancer Genomics Tumor Molecular Pathology (TMP) AWG, G. Getz

The paper identifies five lung adenocarcinoma expression subtypes using consensus hierarchical clustering and finds subtype-specific dependencies on MET, CDK4, CDK6, and PD-L1, which could guide targeted therapies.

bioRxiv · Feb 20, 2022 · PreprintCancer Biology